A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)

NCT07300267 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infection

Interventions

BIOLOGICAL: V118C (Stage 1)
BIOLOGICAL: V118C (Stage 2)
BIOLOGICAL: PCV20 (Stage 1)
BIOLOGICAL: PCV20 (Stage 2)

Sponsor

Merck Sharp & Dohme LLC